Transdermal Drug Delivery Systems Market by Type of Drug Delivery System and Application - Global Industry Analysis and Forecast to 2023
Transdermal Drug Delivery Systems Market from Qurate’s Repository provides detailed information, in-depth analysis, and forecast which is developed by a team of experts and professionals
(EMAILWIRE.COM, August 22, 2018 ) Industry Outlook and Trend Analysis
The global Transdermal Drug Delivery Systems market was worth USD 29.45 billion in 2014 and is expected to reach approximately USD 67.61 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.67% during the forecast period. Transdermal drug delivery systems are a substitution to oral subcutaneous, intravascular, and transmucosal courses, wherein the medications are given through the skin for therapeutic use. Ascend in aged populace and upsurge in number of patients experiencing incessant scatters are foreseen to drive the market development. In addition, rising implementation of third-generation transdermal drug delivery systems, for example, iontophoresis, supports the market development. Nonetheless, inconveniences of these delivery systems, for example, irritation at the site of usage and edema, are anticipated to obstruct the market development.
Request Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54695
Drivers and Restraints
Upsurge in the frequency of disorders, for example, Parkinson's disease, and increment in aged populace have prompted high adoption of transdermaldrug delivery systems. Moreover, advent of innovative treatment procedures, for example, third-generation transdermal drug delivery systems (microneedles), has additionally prompted the market growth. The market has encountered improvement of new adhesives, penetration enhancers, and molecular absorption enhancers that are foreseen to upgrade skin porousness, bringing about development of the scope of medications that are required to be given through transdermal course.
Market Segmentation
The global transdermal drug delivery systems market is fragmented based on type of delivery system and application. On the basis of type, it is grouped into active and passive delivery systems. The passive delivery systems are additionally divided into reservoir system and matrix system. Active delivery systems are sorted into structure based, electrical based and others. By application, it is separated into hormone replacement therapy, motion sickness, smoking cessation, analgesics, cardiovascular disorders, and others.
Regional Outlook and Trend Analysis
Asia-Pacific offers lucrative opportunities for the market development, attributable to existence of vast pool of patients experiencing chronic disorders, for example, hypertension. As indicated by a CADI Research Foundation, hypertension is the most common ailment in India. It is apparent from the way that the quantity of individuals with hypertension is anticipated to increment to 214 million out of 2025 from 118 million in 2000. Thus, high occurrence of cardiovascular disorders, for example, hypertension, makes it a lucrative business sector for transdermal drug delivery systems.
Competitive Insights
The leading players in the market are Endo International plc, GlaxoSmithKline, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Endo International plc, Echo Therapeutics Inc, Acrux and Mylan.
Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54695
The Transdermal Drug Delivery Systems market is segmented as follows-
By Type:
Passive
Reservoir System
Matrix System
Active
Structure Based
Electrical Based
By Application:
Hormone Replacement Therapy
Cardiovascular Disorders
Analgesics
Smoking Cessation
Motion Sickness
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Russia
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
South America
Brazil
Argentina
Columbia
South Africa
Rest of South America
Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Get Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-CMR-HnM-54695
The global Transdermal Drug Delivery Systems market was worth USD 29.45 billion in 2014 and is expected to reach approximately USD 67.61 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.67% during the forecast period. Transdermal drug delivery systems are a substitution to oral subcutaneous, intravascular, and transmucosal courses, wherein the medications are given through the skin for therapeutic use. Ascend in aged populace and upsurge in number of patients experiencing incessant scatters are foreseen to drive the market development. In addition, rising implementation of third-generation transdermal drug delivery systems, for example, iontophoresis, supports the market development. Nonetheless, inconveniences of these delivery systems, for example, irritation at the site of usage and edema, are anticipated to obstruct the market development.
Request Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54695
Drivers and Restraints
Upsurge in the frequency of disorders, for example, Parkinson's disease, and increment in aged populace have prompted high adoption of transdermaldrug delivery systems. Moreover, advent of innovative treatment procedures, for example, third-generation transdermal drug delivery systems (microneedles), has additionally prompted the market growth. The market has encountered improvement of new adhesives, penetration enhancers, and molecular absorption enhancers that are foreseen to upgrade skin porousness, bringing about development of the scope of medications that are required to be given through transdermal course.
Market Segmentation
The global transdermal drug delivery systems market is fragmented based on type of delivery system and application. On the basis of type, it is grouped into active and passive delivery systems. The passive delivery systems are additionally divided into reservoir system and matrix system. Active delivery systems are sorted into structure based, electrical based and others. By application, it is separated into hormone replacement therapy, motion sickness, smoking cessation, analgesics, cardiovascular disorders, and others.
Regional Outlook and Trend Analysis
Asia-Pacific offers lucrative opportunities for the market development, attributable to existence of vast pool of patients experiencing chronic disorders, for example, hypertension. As indicated by a CADI Research Foundation, hypertension is the most common ailment in India. It is apparent from the way that the quantity of individuals with hypertension is anticipated to increment to 214 million out of 2025 from 118 million in 2000. Thus, high occurrence of cardiovascular disorders, for example, hypertension, makes it a lucrative business sector for transdermal drug delivery systems.
Competitive Insights
The leading players in the market are Endo International plc, GlaxoSmithKline, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Endo International plc, Echo Therapeutics Inc, Acrux and Mylan.
Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54695
The Transdermal Drug Delivery Systems market is segmented as follows-
By Type:
Passive
Reservoir System
Matrix System
Active
Structure Based
Electrical Based
By Application:
Hormone Replacement Therapy
Cardiovascular Disorders
Analgesics
Smoking Cessation
Motion Sickness
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Russia
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
South America
Brazil
Argentina
Columbia
South Africa
Rest of South America
Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Get Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-CMR-HnM-54695
Contact Information:
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results